Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Empros Pharma AB

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 More Arrow 1 Less Arrow 0
Earnings before taxes -11,635 More Arrow -10,330 More Arrow -9,177
EBITDA -12,105 More Arrow -11,687 More Arrow -9,213
Total assets 129,574 More Arrow 147,266 Less Arrow 76,665
Current assets 7,961 More Arrow 33,586 Less Arrow 7,885
Current liabilities 1,076 More Arrow 7,133 Less Arrow 4,775
Equity capital 128,498 More Arrow 140,133 Less Arrow 71,890
- share capital 260 Less Arrow 180 Less Arrow 155
Employees (average) 8 Equal arrow 8 Less Arrow 7

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 99.2% Less Arrow 95.2% Less Arrow 93.8%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -9.0% More Arrow -7.0% Less Arrow -12.0%
Current ratio 739.9% Less Arrow 470.9% Less Arrow 165.1%
Return on equity (ROE) -9.1% More Arrow -7.4% Less Arrow -12.8%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 More Arrow 1 Less Arrow 0
Chg. No. of employees % 0% More Arrow 14% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.